SEC Threatens Inspire With Civil Action
The Durham, N.C.-based biopharmaceutical company said it received a Wells Notice last Thursday, which means the SEC has preliminarily decided to recommend an enforcement action.
However, the notice does give Inspire time to respond to the SEC in an attempt to resolve the matter, which resulted from a previously disclosed investigation. Inspire has said it and its officers...
To view the full article, register now.